Beviglia Cancer Models
Small niche oncology pharmacology CRO validating in vivo efficacy of cancer therapies in clinically predictive models.
8 contract research organizations in our directory list both Xenograft Models and Mouse among their capabilities, across 4 countries. 1 reports GLP capability and 1 reports AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.
Showing 8 CROs. Order rotates daily so no lab is permanently listed first.
Small niche oncology pharmacology CRO validating in vivo efficacy of cancer therapies in clinically predictive models.
San Diego oncology CRO offering patient-derived and orthotopic tumor models for in vivo efficacy and translational studies.
Kentucky CRO developing immunodeficient rat and mouse models, offering xenograft efficacy and safety studies in larger rodent hosts.
Berlin oncology CRO with a large collection of patient-derived xenograft models for in vivo efficacy and biomarker studies.
Beijing-based company providing genetically engineered and humanized mouse models with in vivo pharmacology services, especially for oncology and immunology antibody programs.
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…
Texas preclinical CRO offering xenograft and other oncology models, efficacy, pharmacology and toxicology studies.
Lyon oncology CRO providing in vitro and in vivo proof-of-concept studies for anticancer agents, including resistant tumor models.